RYM
30/11/2015 09:45
RELINT
NOT PRICE SENSITIVE
REL: 0945 HRS Ryman Healthcare Limited
RELINT: RYM: Disclosure of Director's Relevant Interests
Disclosure of acquisition or disposal of relevant
interest by director or senior manager
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
To: NZX Limited
And;
Name of Listed Issuer: Ryman Healthcare Limited
Date this disclosure made: 30 November 2015
Date of last disclosure: 25 November 2014
Director(s) or senior manager(s) giving disclosure
Full name(s): Claire Louise Higgins
Name of listed issuer: Ryman Healthcare Limited
Name of related body corporate (if applicable): N/A
Position held in listed issuer: Director
Summary of acquisition or disposal of relevant interest (excluding specified
derivatives)
Class of affected quoted financial products: Ordinary shares in Ryman
Healthcare Limited (NZX security code RYM)
Nature of the affected relevant interest(s): Adam L Higgins Superannuation
Fund holds the shares in which Claire Louise Higgins is a beneficial owner
For that relevant interest,--
(a) number held in class before acquisition or disposal: 7,900 ordinary
shares
(b) number held in class after acquisition or disposal: 12,650 ordinary
shares
(c) current registered holder(s): Unknown
(d) registered holder(s) once transfers are registered: Adam L Higgins
Superannuation Fund
Details of transactions giving rise to acquisition or disposal
Total number of transactions to which notice relates: Two
Details of the transactions requiring disclosure:
(1) Acquisition of 3,400 ordinary shares in an on-market trade agreed on 24
November 2015, for a total consideration of $26,920 ($7.92 per ordinary
share).
(2) Acquisition of 1,350 ordinary shares in an on-market trade agreed on 26
November 2015, for a total consideration of $10,746 ($7.96 per ordinary
share).
Ryman Healthcare Limited has a financial products trading policy that
requires directors to seek prior written clearance from Ryman Healthcare
Limited for trading by them or by trusts, companies and other entities
controlled by them during certain closed periods. Clearance to acquire the
shares was sought, and was granted in accordance with the policy, on 20
November 2015.
Summary of other relevant interests after acquisition or disposal
Class of quoted financial products: N/A
Nature of relevant interest(s): N/A
For that relevant interest,--
(a) number held in class: N/A
(b) current registered holder(s): N/A
Signature of person authorised to sign on behalf of director or officer
Gordon MacLeod
Deputy Chief Executive, Chief Financial Officer and Company Secretary
Ryman Healthcare Limited
Date of signature: 30 November 2015
End CA:00274327 For:RYM Type:RELINT Time:2015-11-30 09:45:15
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
